WithdrawnPhase 2NCT00305201

Cardiovascular Risk Markers and Response to Statins After Kawasaki Disease

Studying Kawasaki disease

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Pontificia Universidad Catolica de Chile
Principal Investigator
Arturo Borzutzky, MD
Pontificia Universidad Catolica de Chile, School of Medicine, Department of Pediatrics
Intervention
pravastatin(drug)
Eligibility
8-25 years · All sexes
Timeline
2006 – 2007

Study locations (1)

Collaborators

Bristol-Myers Squibb

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00305201 on ClinicalTrials.gov

Other trials for Kawasaki disease

Additional recruiting or active studies for the same condition.

See all trials for Kawasaki disease →

← Back to all trials